Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.57 |
| ▸ | CASP2 | P42575 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9577064 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL28346905 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784649 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784660 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL17710344 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL11673516 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL10631525 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784668 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL18784656 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL27655035 | 1.00 | FAAH (0.61) | FAAHSLC6A5DNM1CASP2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2449078-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC POLYMERS AND AMPHOTERIC | The Procter & Gamble Company (US) | 2012-05-09 | — | — | EP | disclosed |
| US-20110269661-A1 | Fabric Care Compositions Comprising Cationic Polymers and Anionic Surfactants | CORONA III ALESSANDRO | 2011-11-03 | — | — | US | disclosed |
| WO-2011002476-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC POLYMERS AND AMPHOTERIC | THE PROCTER & GAMBLE COMPANY (US) | 2011-01-06 | — | — | WO | disclosed |
| US-20100056420-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC POLYMERS AND ANIONIC SURFACTANTS | THE PROCTER & GAMBLE COMPANY | 2010-03-04 | — | — | US | disclosed |
| US-7422990-B2 | Thermal/acoustic insulation product based on mineral wool | SAINT-GOBAIN ISOVER (FR) | 2008-09-09 | — | — | US | disclosed |
| US-20080149880-A1 | THERMAL/ACOUSTIC INSULATION PRODUCT BASED ON MINERAL WOOL AND ITS MANUFACTURING PROCESS | SAINT-GOBAIN ISOVER (FR) | 2008-06-26 | — | — | US | disclosed |
| US-6818632-B2 | 3-(anilinomethylene)oxindoles | SMITHKLINE BEECHAM CORPORATION | 2004-11-16 | — | — | US | disclosed |
| US-20040191210-A1 | Compounds | GLENNON KIMBERLEY CAROLINE (US) | 2004-09-30 | — | — | US | disclosed |
| US-20040101682-A1 | Heatl/acoustic insulation product based on mineral wool | SAINT-GOBAIN ISOVER (FR) | 2004-05-27 | — | — | US | disclosed |
| US-20040053031-A1 | Heat/sound insulation product based on mineral wool and method | SAINT-GOBAIN ISOVER (FR) | 2004-03-18 | — | — | US | disclosed |
| EP-1299319-A1 | HEAT/SOUND INSULATION PRODUCT BASED ON MINERAL WOOL | SAINT-GOBAIN ISOVER (FR) | 2003-04-09 | — | — | EP | disclosed |
| US-6498176-B1 | INHIBITING TUMOR GROWTH VIA INHIBITION OF TUMOR-RELATED ANGIOGENESIS | SMITHKLINEBEECHAM CORPORATION | 2002-12-24 | — | — | US | disclosed |
| US-20020099071-A1 | Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia | GLENNON KIMBERLEY CAROLINE (US) | 2002-07-25 | — | — | US | disclosed |
| US-6369086-B1 | Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors | SMITHKLINE BEECHAM CORPORATION | 2002-04-09 | — | — | US | disclosed |
| US-6350747-B1 | PROTEIN SERINE/THREONINE KINASE AND PROTEIN TYROSINE KINASE ENZYME INHIBITORS; ANGIOGENESIS INHIBITORS; ANTITUMOR AND ANTIPROLIFERATIVE AGENTS | GLAXO WELLCOME INC. | 2002-02-26 | — | — | US | disclosed |
| WO-2002006177-A1 | HEAT/SOUND INSULATION PRODUCT BASED ON MINERAL WOOL | SAINT-GOBAIN ISOVER (FR) | 2002-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040191210-A1 | Compounds | CDK1, AKT1, RPS6KA1 | FAAH 4810/4885SLC6A5 4642/4885DNM1 4067/4885 |
| US-20020099071-A1 | Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia | PRKDC, PRKX, BMX | FAAH 4771/4885SLC6A5 4229/4885DNM1 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.